| 01/05/2013 |
EU funding (€1,493,542): Next Generation Sequencing for Detection of Human Primary Immunodeficiency Syndromes Characterized by Impaired Cytotoxic Lymphocyte Function |
| 01/02/2013 |
EU funding (€1,750,000): The Role of Pericytes in Central Nervous System Scarring and Fibrosis |
| 01/01/2013 |
EU funding (€1,835,081): Platform for Sharing Best Practices for Management of Rare Diseases |
| 01/10/2013 |
EU funding (€10.2M): Grant FP7 - 604305 - SUN |
| 01/03/2013 |
EU funding (€100,000): Support of a European Research Career: Role of Chromatin-Modifying Enzymes in Oligodendrocyte Precursor State in Development and Multiple Sclerosis |
| 01/04/2013 |
EU funding (€10M): Grant FP7 - 309329 - Nanosolutions |
| 01/03/2013 |
EU funding (€10M): Grant FP7 - 310584 - Nanoreg |
| 01/01/2013 |
EU funding (€11.9M): Improving Outcome of Necrotizing Fasciitis: Elucidation of Complex Host and Pathogen Signatures That Dictate Severity of Tissue Infection |
| 01/10/2013 |
EU funding (€12M): Human |
| 01/07/2013 |
EU funding (€157,278): Pief-GA-2011-303313-Obinnsc1-the Physiological Control of Stem Cells: Obesity, Insulin, and Neural Stem Cell Dynamics |
| 01/01/2013 |
EU funding (€181,418): Pief-GA-2011- LGR6Mammarysc - the Role of LGR6 AS a Marker of Progenitor Cells and Cancer-Initiating Cells in the Mammary Gland |
| 01/01/2013 |
EU funding (€192.22): Information is not Available |
| 01/09/2013 |
EU funding (€197,812): Combining Sensitive Biomarkers for Early Diagnosis of AD: a Multi-Modal Approach |
| 12/08/2013 |
EU funding (€197,812): Nudix Hydrolases in Cancer Therapy |
| 01/12/2013 |
EU funding (€2,277,225): Grant FP7 - 604244 - Norosensor |
| 01/03/2013 |
EU funding (€2,330,974): Plasticity and Formation of Lasting Memories in Health and Disease. Genetic Modeling of key Regulators in Adult and Aging Mammals and in Neurodegenerative Disease |
| 01/01/2013 |
EU funding (€2,425,958): A Novel Drug Discovery Method Based on Systems Biology: Combination Therapy and Biomarkers for Multiple Sclerosis |
| 01/01/2013 |
EU funding (€2,499,917): Endometrial and Embryonic Genomics, Searching for Biomarkers in Assisted Reproduction (Short Title: Search for Assisted Reproduction Markers) |
| 01/02/2013 |
EU funding (€2,973,973): Grant FP7 - 313010 - Bbmri-LPC |
| 01/07/2013 |
EU funding (€206,351): Size Matters: Investigating the Link Between Affective and Perceptual Body Representations Using Multisensory Illusions and Brain Imaging |
| 01/09/2013 |
EU funding (€3,017,351): Exploring Functional and Developmental Osteoclast Heterogeneity in Health and Disease |
| 01/06/2013 |
EU funding (€3,467,715): Suicide Bomber Counteraction and Prevention |
| 01/09/2013 |
EU funding (€3,590,008): Control of Metabolic and Inflammatory Pathways by Nuclear Receptors |
| 01/01/2013 |
EU funding (€3,865,282): Vascular Endothelial Interactions and Specialization |
| 01/08/2013 |
EU funding (€3,879,323): WNT-Mediated Signal Relay in Stem Cells and Oncogenesis - From Basic Biology to Applications |
| 01/02/2013 |
EU funding (€3,906,630): European School of DNA Nanotechnology |
| 01/10/2013 |
EU funding (€30M): Center-TBI |
| 01/01/2013 |
EU funding (€363,676): Irisin - a Novel Myokine Protective Against Metabolic Disease |
| 01/10/2013 |
EU funding (€4,003,246): Label Free Particle Sorting |
| 01/02/2013 |
EU funding (€4,300,000): Grant FP7 - 313010 - Bbmri-LPC |
| 01/09/2013 |
EU funding (€5,305,735): Mindview |
| 01/10/2013 |
EU funding (€5,381,933): Counterstroke |
| 01/12/2013 |
EU funding (€5,397,664): Closed |
| 01/11/2013 |
EU funding (€5,542,187): Coheahr |
| 01/01/2013 |
EU funding (€5,648,390): Healthy Aging through Internet Counselling in the Elderly |
| 01/09/2013 |
EU funding (€5,876,992): Athero-B-Cell |
| 01/09/2013 |
EU funding (€5,903,843): Athero-Flux |
| 01/10/2013 |
EU funding (€5,935,893): Grant FP7 - 602278 - Neurostemcellrepair |
| 01/10/2013 |
EU funding (€5,943,785): EU-Cert-ICD |
| 01/10/2013 |
EU funding (€5,973,521): Cartardis |
| 01/04/2013 |
EU funding (€5,975,032): King of Hearts, Joints and Lungs; Periodontal Pathogens as Etiologic Factor in RA, CVD and Copd and Their Impact on Treatment Strategies. |
| 01/12/2013 |
EU funding (€5,994,233): VIA |
| 01/11/2013 |
EU funding (€5,997,079): Gloria |
| 01/02/2013 |
EU funding (€5,999,231): Pathway-27 |
| 01/09/2013 |
EU funding (€500,000): Earip |
| 01/09/2013 |
EU funding (€500,000): Implement |
| 01/08/2013 |
EU funding (€595,512): Factor XII and the Contact System:
Cross-Talk Between Thrombosis and Inflammation |
| 01/11/2013 |
EU funding (€7,279,203): Grant FP7 - 613879 - Synsignal |
| 01/08/2013 |
EU funding (€744,390): Factor XII and the Contact System:
Cross-Talk Between Thrombosis and Inflammation |
| 01/01/2013 |
EU funding (€799,773): Irisin - a Novel Myokine Protective Against Metabolic Disease |
| 01/01/2013 |
EU funding (€9,569,598): Infra-2012-1.1.4.-312325 - GA 312325 Infrafrontier - SP4-Capacities - Combination of CP & CSA - Integrating Activities / E-Infrastructuers-2012-1 - Infrafrontier-13 - Infra-2012-1.1.4. |
| 01/12/2013 |
EU funding (€980,742): Grant FP7 - 604244 - Norosensor |
